Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021

SELL
$177.8 - $270.58 $259,588 - $395,046
-1,460 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$121.0 - $257.67 $1.26 Million - $2.68 Million
-10,386 Reduced 87.68%
1,460 $309,000
Q1 2021

May 06, 2021

SELL
$112.98 - $319.93 $860,681 - $2.44 Million
-7,618 Reduced 39.14%
11,846 $2.15 Million
Q4 2020

Feb 01, 2021

BUY
$78.74 - $139.5 $270,393 - $479,043
3,434 Added 21.42%
19,464 $2.17 Million
Q3 2020

Oct 29, 2020

SELL
$79.44 - $178.51 $282,012 - $633,710
-3,550 Reduced 18.13%
16,030 $1.74 Million
Q2 2020

Aug 11, 2020

BUY
$13.86 - $83.61 $271,378 - $1.64 Million
19,580 New
19,580 $1.63 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Harvest Investment Services, LLC Portfolio

Follow Harvest Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Investment Services, LLC with notifications on news.